United States · FDA National Drug Code directory
Cefdinir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71205-576_c28dd37d-af86-4e03-b5cd-7be2bb9aaff2
- Product NDC
- 71205-576
- Form
- CAPSULE
- Composition / generic term
- Cefdinir
- Labeler
- Proficient Rx LP
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210220
- Source listing expiry
- 20271231
Source-listed ingredients
- CEFDINIR — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 CAPSULE in 1 BOTTLE (71205-576-06) · 71205-576-06
- 10 CAPSULE in 1 BOTTLE (71205-576-10) · 71205-576-10
- 14 CAPSULE in 1 BOTTLE (71205-576-14) · 71205-576-14
- 20 CAPSULE in 1 BOTTLE (71205-576-20) · 71205-576-20
- 30 CAPSULE in 1 BOTTLE (71205-576-30) · 71205-576-30
- 60 CAPSULE in 1 BOTTLE (71205-576-60) · 71205-576-60
- 90 CAPSULE in 1 BOTTLE (71205-576-90) · 71205-576-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →